- Home
- BVFL vs KRRO Comparison
BVFL vs KRRO Comparison
Compare BVFL & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVFL
- KRRO
- Stock Information
- Founded
- BVFL 1873
- KRRO 2014
- Country
- BVFL United States
- KRRO United States
- Employees
- BVFL N/A
- KRRO N/A
- Industry
- BVFL Savings Institutions
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- BVFL Finance
- KRRO Health Care
- Exchange
- BVFL Nasdaq
- KRRO Nasdaq
- Market Cap
- BVFL 150.2M
- KRRO 147.4M
- IPO Year
- BVFL N/A
- KRRO 2019
- Fundamental
- Price
- BVFL $16.25
- KRRO $20.26
- Analyst Decision
- BVFL
- KRRO Strong Buy
- Analyst Count
- BVFL 0
- KRRO 8
- Target Price
- BVFL N/A
- KRRO $96.71
- AVG Volume (30 Days)
- BVFL 44.9K
- KRRO 142.2K
- Earning Date
- BVFL 07-17-2025
- KRRO 08-12-2025
- Dividend Yield
- BVFL N/A
- KRRO N/A
- EPS Growth
- BVFL 27.12
- KRRO N/A
- EPS
- BVFL 1.07
- KRRO N/A
- Revenue
- BVFL $38,333,000.00
- KRRO $6,281,000.00
- Revenue This Year
- BVFL N/A
- KRRO $65.08
- Revenue Next Year
- BVFL N/A
- KRRO N/A
- P/E Ratio
- BVFL $15.31
- KRRO N/A
- Revenue Growth
- BVFL 2.48
- KRRO N/A
- 52 Week Low
- BVFL $13.53
- KRRO $10.29
- 52 Week High
- BVFL $18.19
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- BVFL 60.81
- KRRO 70.12
- Support Level
- BVFL $15.18
- KRRO $14.15
- Resistance Level
- BVFL $16.72
- KRRO $16.89
- Average True Range (ATR)
- BVFL 0.34
- KRRO 1.67
- MACD
- BVFL 0.08
- KRRO 0.46
- Stochastic Oscillator
- BVFL 69.87
- KRRO 93.51
About BVFL BV Financial Inc.
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.